These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease. Bowler JV Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580 [No Abstract] [Full Text] [Related]
3. [Medical treatment of Alzheimer's disease]. Johannsen P Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609 [TBL] [Abstract][Full Text] [Related]
4. Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature. Bullock R; Truyen L Int J Geriatr Psychiatry; 2005 Jan; 20(1):85-7; author reply 87-9. PubMed ID: 15635772 [No Abstract] [Full Text] [Related]
5. [Donepezil in Alzheimer's disease and vascular dementia]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452 [No Abstract] [Full Text] [Related]
6. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276 [No Abstract] [Full Text] [Related]
7. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine. Capellà D; Vidal X Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086 [No Abstract] [Full Text] [Related]
9. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
10. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. Gasser US; Gasser T MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165 [No Abstract] [Full Text] [Related]
11. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420 [TBL] [Abstract][Full Text] [Related]
14. [Advances in Alzheimer's disease treatment]. Nourhashémi F Rev Med Interne; 2006 Aug; 27(8):585-7. PubMed ID: 16782240 [No Abstract] [Full Text] [Related]
15. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522 [TBL] [Abstract][Full Text] [Related]
16. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related]